These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34981299)

  • 21. Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway.
    Zhang L; Wang Y; Su H
    Neoplasma; 2020 Jul; 67(4):762-772. PubMed ID: 32726126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
    Zhang L; Liu Z; Dong Y; Kong L
    Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
    Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
    Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
    Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
    Zhang LN; Zhao L; Yan XL; Huang YH
    J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of lnc-ZNF281 Inhibits the Progression of Glioma via the AKT/GSK-3
    Deng YQ; Kong GY; Li S; Li F; Wen SL
    J Immunol Res; 2021; 2021():5573071. PubMed ID: 34056009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CBX2 Induces Glioma Cell Proliferation and Invasion Through the Akt/PI3K Pathway.
    Wang L; Ren B; Zhuang H; Zhong Y; Nan Y
    Technol Cancer Res Treat; 2021; 20():15330338211045831. PubMed ID: 34709960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
    Ni H; Ji D; Huang Z; Li J
    Arch Biochem Biophys; 2020 Nov; 695():108628. PubMed ID: 33049294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
    Yu X; Wang M; Wu J; Han Q; Zhang X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of TRIM47 inhibits glioma cell proliferation, migration and invasion through the inactivation of Wnt/β-catenin pathway.
    Chen L; Li M; Li Q; Xu M; Zhong W
    Mol Cell Probes; 2020 Oct; 53():101623. PubMed ID: 32603762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TSG101 Promotes the Proliferation, Migration, and Invasion of Human Glioma Cells by Regulating the AKT/GSK3β/β-Catenin and RhoC/Cofilin Pathways.
    Zhu Y; Xu Y; Chen T; Zhang Y; Ma Q; Rauniyar S; Wang L; Shi H
    Mol Neurobiol; 2021 May; 58(5):2118-2132. PubMed ID: 33411238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOX15 exerts antitumor function in glioma by inhibiting cell proliferation and invasion via downregulation of Wnt/β-catenin signaling.
    Zhang D; Guo S; Wang H; Hu Y
    Life Sci; 2020 Aug; 255():117792. PubMed ID: 32416168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
    Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
    Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of lncRNA LSINCT5 suppresses growth and metastasis of human glioma cells via up-regulating miR-451.
    Liu B; Cao W; Ma H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2507-2515. PubMed ID: 31213092
    [No Abstract]   [Full Text] [Related]  

  • 36. HOXB7 promotes proliferation and metastasis of glioma by regulating the Wnt/β-catenin pathway.
    Huo XY; Zhang XY; Yuan F; Zhao XY; You BA
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2476-2485. PubMed ID: 30964174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway.
    Wang F; Zhu W; Yang R; Xie W; Wang D
    Mol Cell Biochem; 2019 Jun; 456(1-2):73-83. PubMed ID: 30635820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription.
    Han L; Yang Y; Yue X; Huang K; Liu X; Pu P; Jiang H; Yan W; Jiang T; Kang C
    Brain Res; 2010 Dec; 1366():9-17. PubMed ID: 20888802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of lncRNA-UCA1 inhibits cell viability and migration of human glioma cells by miR-193a-mediated downregulation of CDK6.
    Xin H; Liu N; Xu X; Zhang J; Li Y; Ma Y; Li G; Liang J
    J Cell Biochem; 2019 Sep; 120(9):15157-15169. PubMed ID: 31111564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.